Rtw Investments, LP Argenx Se Transaction History
Rtw Investments, LP
- $6.27 Billion
- Q3 2024
A detailed history of Rtw Investments, LP transactions in Argenx Se stock. As of the latest transaction made, Rtw Investments, LP holds 654,430 shares of ARGX stock, worth $369 Million. This represents 5.66% of its overall portfolio holdings.
Number of Shares
654,430
Previous 654,430
-0.0%
Holding current value
$369 Million
Previous $281 Million
26.11%
% of portfolio
5.66%
Previous 4.7%
Shares
19 transactions
Others Institutions Holding ARGX
# of Institutions
400Shares Held
30.9MCall Options Held
376KPut Options Held
489K-
Price T Rowe Associates Inc Baltimore, MD5.82MShares$3.28 Billion0.36% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI3.51MShares$1.98 Billion2.99% of portfolio
-
Janus Henderson Group PLC London, X02.48MShares$1.4 Billion0.72% of portfolio
-
Capital World Investors Los Angeles, CA1.7MShares$959 Million0.15% of portfolio
-
Avoro Capital Advisors LLC New York, NY1.24MShares$699 Million10.11% of portfolio
About ARGENX SE
- Ticker ARGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,323,800
- Market Cap $31.2B
- Description
- argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...